Transfusion Medicine Reviews
Volume 20, Issue 2 , Pages 110-140 , April 2006

Bystander Immune Cytolysis

  • Lawrence D. Petz

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Lawrence D. Petz, MD, StemCyte International Cord Blood Center, 400 Rolyn Place, Arcadia, CA 91007.

References 

  1. Petz LD, Garratty G. Historical concepts of immune hemolytic anemias. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 1–31
  2. Dameshek W. Autoimmunity: Theoretical aspects. Ann. N. Y. Acad. Sci. 1965;124:6–28
  3. Petz LD, Garratty G. Bystander immune hemolysis. In:  Petz LD,  Garratty G editor. Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 358–364
  4. Thompson RA, Rowe DS. Reactive haemolysis—a distinctive form of red cell lysis. Immunology. 1968;14:745–762
  5. Thompson RA, Lachmann PJ. Reactive lysis: The complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J. Exp. Med. 1970;131:629–641
  6. Lachmann PJ, Thompson RA. Reactive lysis: The complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J. Exp. Med. 1970;131:643–657
  7. Götze O, Muller-Eberhard HJ. Lysis of erythrocytes by complement in the absence of antibody. J. Exp. Med. 1970;132:898–915
  8. Goldman JN, Ruddy S, Austen KF. Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9. J. Immunol. 1972;109:353–359
  9. McLeod BC, Baker P, Gewurz H. Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH—an inhibitor of the C567 trimolecular complex of complement. Int. Arch. Allergy Appl. Immunol. 1974;47:623–632
  10. Salama A, Mueller Eckhardt C. Binding of fluid phase C3b to nonsensitized bystander human red cells. A model for in vivo effects of complement activation on blood cells. Transfusion. 1985;25:528–534
  11. Salama A, Bhakdi S, Mueller-Eckhardt C. Evidence suggesting the occurrence of C3-independent intravascular immune hemolysis. Reactive hemolysis in vivo. Transfusion. 1987;27:49–53
  12. Gajewski JL, Petz LD, Calhoun L, et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood. 1992;79:3076–3085
  13. Petz LD. The expanding boundaries of transfusion medicine. In:  Nance SJ editors. Clinical and basic science aspects of immunohematology. Arlington, VA: American Association of Blood Banks; 1991;p. 73–113
  14. Petz LD, Garratty G. Immune hemolysis associated with transplantation. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 459–516
  15. Hows J, Beddow K, Gordon Smith E, et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood. 1986;67:177–181
  16. Petz LD. Immunohematologic problems associated with bone marrow transplantation. Transfus. Med. Rev. 1987;1:85–100
  17. Toren A, Dacosta Y, Manny N, et al. Passenger B-lymphocyte–induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood. 1996;87:843–844
  18. Greeno EW, Perry EH, Ilstrup SJ, et al. Exchange transfusion the hard way: Massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion. 1996;36:71–74
  19. Oziel-Taieb S, Faucher-Barbey C, Chabannon C, et al. Early and fatal immune haemolysis after so-called ‘minor’ ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant. 1997;19:1155–1156
  20. Broketa G, Simpson JK, Hammert L, et al. Delayed hemolysis after minor ABO mismatched peripheral blood stem cell transplantation. Transfusion. 1997;37:37S
  21. Bolan CD, Childs RW, Procter JL, et al. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br. J. Haematol. 2001;112:787–795
  22. Petz LD. Hemolysis associated with transplantation. Transfusion. 1998;38:224–228
  23. Petz LD. Immunohematologic problems unique to bone marrow transplantation. In:  Garratty G editors. Red cell antigens and antibodies. Arlington, VA: AABB; 1986;p. 195–229
  24. von Tol MJD, Gerritsen EJA, de Lange GG, et al. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood. 1996;87:818–826
  25. Swanson JL, Sastamoinen RM, Steeper TA, et al. Gm allotyping to determine the origin of red cell antibodies in recipients of solid organ transplants. Vox Sang. 1987;52:75–78
  26. Laurencet FM, Samii K, Bressoud A, et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol. Cell Ther. 1997;39:159–162
  27. Tiplady CW, Fitzgerald JM, Jackson GH, et al. Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant. Transfus. Med. 2001;11:455–458
  28. Worel N, Greinix HT, Keil F, et al. Severe immune hemolysis after minor ABO-incompatible allogeneic peripheral blood stem cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion. 2002;42:1293–1301
  29. Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion. 2002;42:198–204
  30. Rowley SD. Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant. 2001;28:315–321
  31. Herzog P, Korinkova P, Stambergova M, et al. Auto anti-A1 and auto anti-NA1 after bone marrow transplantation. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 1987;114:874–880
  32. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37:382–392
  33. Chaplin H, Cassell M. The occasional fallibility of in vitro compatibility tests. Transfusion. 1962;2:375
  34. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion. 1997;37:357–361
  35. Diamond WJ, Brown FL, Bitterman P, et al. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann. Intern. Med. 1980;93:231–233
  36. Milner PF, Squires JE, Larison PJ, et al. Posttransfusion crises in sickle cell anemia: Role of delayed hemolytic reactions to transfusion. South. Med. J. 1985;78:1462–1469
  37. Talano JA, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003;111:661–665
  38. Reed W, Walker P, Haddix T, et al. Acute anemic events in sickle cell disease. Transfusion. 2000;40:267–273
  39. King KE, Shirey RS, Lankiewicz MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: Simultaneous destruction of recipients' red cells. Transfusion. 1997;37:376–381
  40. Cullis JO, Win N, Dudley JM, et al. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: Use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang. 1995;69:355–357
  41. Petz LD, Garratty G. Hemolytic transfusion reactions. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 541–572
  42. Petz LD, Garratty G. The sickle cell hemolytic transfusion reaction syndrome. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 547–555
  43. Chaplin H, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch. Intern. Med. 1981;141:1091–1093
  44. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion. 2001;41:323–328
  45. Syed SK, Sears DA, Werch JB, et al. Case reports: Delayed hemolytic transfusion reaction in sickle cell disease. Am. J. Med. Sci. 1996;312:175–181
  46. Sosler SD, Perkins JT, Saporito C, et al. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease. Transfusion. 1989;29:49S;(abstr)
  47. Friedman DF, Kim HC, Manno CS. Hyperhemolysis associated with red cell transfusion in sickle cell disease. Transfusion. 1993;33:14S;(abstr)
  48. Campbell SA, Shirey RS, King KE, et al. An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion. 2000;40:828–831
  49. Sirchia G, Morelati F, Rebulla P. The sickle cell hemolytic transfusion reaction syndrome. [letter] Transfusion. 1997;37:1098–1099
  50. Grainger JD, Makar Y, McManus A, et al. Refractory hyperhaemolysis in a patient with beta-thalassaemia major. Transfus. Med. 2001;11:55–57
  51. Petz LD. Blood transfusion in hemolytic anemias. Immunohematology. 1999;15:15–23
  52. Beutler E. Production and destruction of erythrocytes. In:  Beutler E,  Lichtman MA,  Coller BS, et al. editor. Williams hematology. ed. 6. Inc., New York: McGraw-Hill; 2001;p. 355–368
  53. Hillman RS, Finch CA. Erythropoiesis: Normal and abnormal. Semin. Hematol. 1967;4:327–336
  54. Ballas SK, Gay RN. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37:1099–1100
  55. Diggs LW. The crisis in sickle cell anemia. Hematological studies. Am. J. Clin. Pathol. 1956;26:1109–1118
  56. Diggs LW. Sickle crises. Am. J. Clin. Pathol. 1965;44:1–19
  57. Naumann HN, Diggs LW, Barreras L, et al. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am. J. Clin. Pathol. 1971;56:137–147
  58. Telen MJ. Principles and problems of transfusion in sickle cell disease. Semin. Hematol. 2001;38:315–323
  59. Petz LD, Garratty G. Drug-induced immune hemolytic anemia. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 261–317
  60. Petz LD, Garratty G. Development of RBC autoantibodies and AIHA following transfusion. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 335–340
  61. Cox KO, Keast D. Erythrocyte autoantibodies induced in mice immunized with rat erythrocytes. Immunology. 1973;25:531–539
  62. Cox KO, Keast D. Autoimmune haemolytic anaemia induced in mice immunized with rat erythrocytes. Clin. Exp. Immunol. 1974;17:319–327
  63. Naysmith JD, Ortega-Pierres MG, Elson CJ. Rat erythrocyte-induced anti-erythrocyte autoantibody production and control in normal mice. Immunol. Rev. 1981;55:55–87
  64. Cook IA. Primary rhesus immunization of male volunteers. Br. J. Haematol. 1971;20:369–375
  65. Beard ME, Pemberton J, Blagdon J, et al. Rh immunization following incompatible blood transfusion and a possible long-term complication of anti–D immunoglobulin therapy. J. Med. Genet. 1971;8:317–320
  66. Lalezari P, Talleyrand NP, Wenz B, et al. Development of direct antiglobulin reaction accompanying alloimmunization in a patient with Rhd (D, category III) phenotype. Vox Sang. 1975;28:19–24
  67. Argiolu F, Diana G, Arnone M, et al. High-dose intravenous immunoglobulin in the management of autoimmune hemolytic anemia complicating thalassemia major. Acta Haematol. 1990;83:65–68
  68. Chan D, Poole GD, Binney M, et al. Severe intravascular hemolysis due to autoantibodies stimulated by blood transfusion. Immunohematology. 1996;12:80–83
  69. Zumberg MS, Procter JL, Lottenberg R, et al. Autoantibody formation in the alloimmunized red blood cell recipient: Clinical and laboratory implications. Arch. Intern. Med. 2001;161:285–290
  70. Wodzinski MA, Collin RC, Booker DJ, et al. Delayed hemolytic transfusion reaction and paroxysmal cold hemoglobinuria: An unusual association. Immunohematology. 1997;13:54
  71. Dameshek W, Levine P. Isoimmunization with Rh factor in acquired hemolytic anemia. N. Engl. J. Med. 1943;228:641–644
  72. Mohn JF, Lanbert RB, Bowman HS, et al. Experimental production in man of autoantibodies with Rh specificity. Ann. N. Y. Acad. Sci. 1965;124:477
  73. Mohn JF, Bowman HS, Lambert RM, et al. The formation of Rh specific autoantibodies in experimental isoimmune hemolytic anemia in man. In: Tenth Congress of the International Society for Blood Transfusion, Stockholm. 1964;
  74. Smith LJ. Paroxysmal nocturnal hemoglobinuria. Clin. Lab. Sci. 2004;17:172–177
  75. Young NS. Paroxysmal nocturnal hemoglobinuria: Current issues in pathophysiology and treatment. Curr. Hematol. Rep. 2005;4:103–109
  76. Beutler E. Paroxysmal nocturnal hemoglobinuria. In:  Beutler E,  Lichtman MA,  Coller BS, et al. editor. Williams hematology. ed. 6. New York: McGraw-Hill; 2001;p. 419–424
  77. Sirchia G, Ferrone S, Mercuriali F. Leukocyte antigen-antibody reaction and lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Blood. 1970;36:334–336
  78. Rosse WF. Paroxysmal nocturnal hemoglobinuria: The biochemical defects and the clinical syndrome. Blood Rev. 1989;3:192–200
  79. Nakakuma H. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH). Am. J. Hematol. 1996;53:22–29
  80. Nakakuma H, Hidaka M, Nagakura S, et al. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation. J. Clin. Invest. 1995;96:201–206
  81. Polesky HF, Bove JR. A fatal hemolytic transfusion reaction with acute autohemolysis. Transfusion. 1964;4:285–292
  82. Weiner AS. Hemolytic reactions following transfusion of blood of the homologous group. Arch. Pathol. 1941;32:227–250
  83. Greene D, Khan S. A phenomenon of delayed hemolytic transfusion reaction. Transfusion. 1991;31:23S;(abstr)
  84. Shulman NR. Posttransfusion purpura: Clinical features and the mechanism of platelet destruction. In:  Nance ST editors. Clinical and basic science aspects of immunohematology. Arlington, VA: American Association of Blood Banks; 1991;p. 137–154
  85. Mueller-Eckhardt C. Post-transfusion purpura. Br. J. Haematol. 1986;64:419–424
  86. Lau P, Sholtis CM, Aster RH. Post-transfusion purpura: An enigma of alloimmunization. Am. J. Hematol. 1980;9:331–336
  87. George JN, Rizvi MA. Posttransfusion purpura. In:  Beutler E,  Lichtman MA,  Coller BS editor. Williams hematology. ed. 6. New York: McGraw Hill; 2001;p. 1526–1527
  88. Petz LD, Garratty G. AIHA and infectious agents. In: Immune hemolytic anemias. ed. 2. Philadelphia: Churchill Livingstone; 2004;p. 99–110
  89. Berkowitz FE. Hemolysis and infection: Categories and mechanisms of their interrelationship. Rev. Infect. Dis. 1991;13:1151–1162
  90. Janney FA, Lee LT, Howe C. Cold hemagglutinin cross-reactivity with Mycoplasma pneumoniae. Infect. Immun. 1978;22:29–33
  91. Loomes LM, Uemura K, Childs RA, et al. Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type. Nature. 1984;307:560–563
  92. Donath J, Landsteiner K. Uber Kaltehaemoglobinurie. Ergeb. Hyg. Bakteriol. 1925;7:184–228
  93. Becker RM. Paroxysmal cold hemoglobinurias. Arch. Intern. Med. 1948;81:630–648
  94. Nabarro D. Congenital syphilis. London: Arnold; 1954;
  95. Dacie JV. Auto-immune haemolytic anaemia (AIHA): cold-antibody syndromes. V: Paroxysmal cold haemoglobinuria (PCH). In:  Dacie JV editors. The haemolytic anaemias. ed. 3. The auto-immune haemolytic anaemias. vol 3:New York: Churchill Livingstone; 1992;p. 329–362
  96. Sokol RJ, Booker DJ, Stamps R. Erythropoiesis: Paroxysmal cold haemoglobinuria: A clinico-pathological study of patients with a positive Donath-Landsteiner test. Hematology. 1999;4:137–164
  97. Sabio H, Jones D, McKie VC. Biphasic hemolysin hemolytic anemia: Reappraisal of an acute immune hemolytic anemia of infancy and childhood. Am. J. Hematol. 1992;39:220–222
  98. Bunch C, Schwartz FC, Bird GW. Paroxysmal cold haemoglobinuria following measles immunization. Arch. Dis. Child. 1972;47:299–300
  99. O'Neill BJ, Marshall WC. Paroxysmal cold haemoglobinuria and measles. Arch. Dis. Child. 1967;42:183–186
  100. Colley EW. Paroxysmal cold haemoglobinuria after mumps. BMJ. 1964;1:1552–1553
  101. Sokol RJ, Hewitt S, Stamps BK, et al. Autoimmune haemolysis in childhood and adolescence. Acta Haematol. 1984;72:245–257
  102. Papalia MA, Schwarer AP. Paroxysmal cold haemoglobinuria in an adult with chicken pox. Br. J. Haematol. 2000;109:328–329
  103. Nakamura H, Watanabe T, Hayashida T, et al. Donath-Landsteiner antibody of the IgM class with anti-I specificity and possible efficacy of azathioprine therapy in paroxysmal cold hemoglobinuria: A case report. Rinsho Ketsueki. 1990;31:1548–1552
  104. Chambers LA, Rauck AM. Acute transient hemolytic anemia with a positive Donath-Landsteiner test following parvovirus B19 infection. J. Pediatr. Hematol. Oncol. 1996;18:178–181
  105. Wolach B, Heddle N, Barr RD, et al. Transient Donath-Landsteiner haemolytic anaemia. Br. J. Haematol. 1981;48:425–434
  106. Wishart MM, Davey MG. Infectious mononucleosis complicated by acute haemolytic anaemia with a positive Donath-Landsteiner reaction. J. Clin. Pathol. 1973;26:332–334
  107. Burkhart PT, Hsu TCS. IgM cold-warm hemolysins in infectious mononucleosis. Transfusion. 1979;19:535–538
  108. Uzokwe CO, Gwynn AM, Gorst DW, et al. Infectious mononucleosis complicated by haemolytic anaemia due to the Donath Landsteiner antibody and by severe neutropenia. Clin. Lab. Haematol. 1993;15:137–140
  109. Engelfriet CP, Beckers D, Borne vd AE, et al. Haemolysins probably recognizing the antigen p. Vox Sang. 1972;23:176–181
  110. Boccardi V, D'Annibali S, Di Natale G, et al. Mycoplasma pneumoniae infection complicated by paroxysmal cold hemoglobinuria with anti-P specificity of biphasic hemolysin. Blut. 1977;34:211–214
  111. Lau P, Sererat S, Moore V, et al. Paroxysmal cold hemoglobinuria in a patient with Klebsiella pneumonia. Vox Sang. 1983;44:167–172
  112. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis associated with Donath-Landsteiner antibodies. Acta Haematol. 1982;68:268–277
  113. Daniel-Ribeiro CT, Zanini G. Autoimmunity and malaria: What are they doing together?. Acta Trop. 2000;76:205–221
  114. Facer CA, Bray RS, Brown J. Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity. Clin. Exp. Immunol. 1979;35:119–127
  115. Drouin J, Rock G, Jolly EE. Plasmodium falciparum malaria mimicking autoimmune hemolytic anemia during pregnancy. CMAJ. 1985;132:265–267
  116. Brown KN, Berzins K, Jarra W, et al. Immune responses to erythrocytic malaria. Clin. Immunol. Allergy. 1986;6:227
  117. Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J. Autoimmun. 2001;16:309–318
  118. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J. Autoimmun. 1996;9:699–703
  119. Downes KA, Domen RE, McCarron KF, et al. Acute autoimmune hemolytic anemia following DTP vaccination: Report of a fatal case and review of the literature. Clin. Pediatr. 2001;40:355–358
  120. Olcay L, Duzova A, Gumruk F. A warm antibody mediated acute hemolytic anemia with reticulocytopenia in a four-month-old girl requiring immunosuppressive therapy. Turk. J. Pediatr. 1999;41:239–244
  121. Seltsam A, Shukry-Schulz S, Salama A. Vaccination-associated immune hemolytic anemia in two children. Transfusion. 2000;40:907–909
  122. Martinez E, Domingo P. Evans's syndrome triggered by recombinant hepatitis B vaccine. Clin. Infect. Dis. 1992;15:1051
  123. Yachnin S, Ruthenberg JM. The initiation and enhancement of human red cell lysis by activators of the first component of complement and by first component esterase; Studies using normal red cells and red cells from patients with paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 1965;44:518–534
  124. Yachnin S. The hemolysis of red cells from patients with paroxysmal nocturnal hemoglobinuria by partially purified subcomponents of the third complement component. J. Clin. Invest. 1965;44:1534–1546
  125. Garratty G. Novel mechanisms for immune destruction of circulating autologous cells. In:  Silberstein LE editors. Autoimmune disorders of blood. Bethesda, MD: American Association of Blood Banks; 1996;p. 79–114
  126. Gocke DJ. In vitro studies of the plasma requirement in platelet damage by an unrelated antigen-antibody reaction. Fed. Proc. 1964;23:404
  127. Salama A, Mueller-Eckhardt C. Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion. 1984;24:188–193
  128. Ness PM, Shirey RS, Thoman SK, et al. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: Incidence, long-term serologic findings, and clinical significance. Transfusion. 1990;30:688–693
  129. Crookston MC, Tilley CA. A and B Lewis antigens in plasma. In: Proceedings of the Fifth International Convocation on Immunologics. Basel, Switzerland: Karger; 1977;p. 246–256
  130. Hostrup H. A and B blood group substances in the serum of normal subjects. Vox Sang. 1962;7:701–721
  131. Holburn AM, Masters CA. The radioimmunoassay of serum and salivary blood group A and Lea glycoproteins. Br. J. Haematol. 1974;28:157–167
  132. Renton PH, Hancock JA. Uptake of A and B antigens by transfused group O erythrocytes. Vox Sang. 1962;7:33–38
  133. Maeda K, Taniwaki K, Santo T, et al. Anti-A and/or anti-B is not detectable in some patients who underwent ABO-incompatible bone marrow transplantation. Transfusion. 1995;35:635–639
  134. Arndt PA, Leger RM, Garratty G, et al. Use of flow cytometry for detecting uptake of A/B blood group substance on transfused/transplanted O RBCs. Transfusion. 1999;39:43S–44SAbstr, (suppl)
  135. Safai-Kutti S, Zaroulis CG, Day NK, et al. Platelet transfusion therapy and circulating immune complexes. Vox Sang. 1980;39:22–27
  136. Kutti J, Zaroulis CG, Safai-Kutti S, et al. Evidence that circulating immune complexes remove transfused platelets from the circulation. Am. J. Hematol. 1981;11:255–259
  137. Heal JM, Cowles J, Masel D, et al. Antibodies to plasma proteins: An association with platelet transfusion refractoriness. Br. J. Haematol. 1992;80:83–90
  138. Miescher PA, Miescher A. Die sedormid-anaphylaxie. Schweiz. Med. Wochenschr. 1952;82:1279
  139. Miescher PA, Pepper JJ. Drug-induced immunologic blood dyscrasias. In:  Miescher PA,  Muller-Eberhard HJ editor. Textbook of immunopathology. New York: Grune and Stratton; 1976;p. 421–432
  140. Shulman NR, Reid DM. Mechanisms of drug-induced immunologically mediated cytopenias. Transfus. Med. Rev. 1993;7:215–229
  141. Worlledge SM, Carstairs KC, Dacie JV. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet. 1966;2:135–139
  142. Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br. J. Haematol. 1985;61:139–143
  143. Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: A unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus. Med. Rev. 1990;4:69–77
  144. Garratty G. Drug-induced immune hemolytic anemia. In:  Garratty G editors. Immunobiology of transfusion medicine. NewYork: Marcel Dekker, Inc; 1994;p. 523–551
  145. Garratty G. Target antigens for red cell-bound autoantibodies. In:  Nance SJ editors. Clinical and serological aspects of immunohematology. Arlington, VA: American Association of Blood Banks; 1991;p. 33
  146. Marks JD, Ouwehand WH, Bye JM, et al. Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (New York). 1993;11:1145–1149
  147. Ouwehand WH, Bye JM, Gorick BD, et al. The humoral immune response against blood group antigens at the molecular level. Vox Sang. 1994;67:7–12(Suppl 3)
  148. Thompson KM, Sutherland J, Barden G, et al. Human monoclonal antibodies specific for blood group antigens demonstrate multispecific properties characteristic of natural autoantibodies. Immunology. 1992;76:146–157
  149. Barker RN, Elson CJ. Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro. Eur. J. Immunol. 1994;24:1578–1582
  150. Shirey RS, Ness PM. New concepts of delayed hemolytic transfusion reactions. In:  Nance SJ editors. Clinical and basic science: Aspects of immunohematology. Arlington, VA: American Association of Blood Banks; 1991;p. 179
  151. Issitt PD, Zellner DC, Rolih SD, et al. Autoantibodies mimicking alloantibodies. Transfusion. 1977;17:531–538
  152. Issitt PD, Pavone BG. Critical re-examination of the specificity of auto–anti-Rh antibodies in patients with a positive direct antiglobulin test. Br. J. Haematol. 1978;38:63–74

PII: S0887-7963(05)00108-2

doi: 10.1016/j.tmrv.2005.11.002

Transfusion Medicine Reviews
Volume 20, Issue 2 , Pages 110-140 , April 2006

Article Tools

* Image Usage & Resolution